Leuplinforection and malignant neoplasm progression Patient Reports February 11, 2012

Leuplinforection Side Effects Report #5214768-8
Leuplinforection side effect was reported by a Consumer or non-health professional from JAPAN on Jan 15, 2007. Male patient, 67 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuplinforection. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, cancer pain, gamma-glutamyltransferase increased, hot flush, malignant neoplasm progression, prostate cancer stage iv. Leuplinforection dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX, DECADRON. Patient was hospitalized. Patient died.

Leuplinforection Side Effects Report #5767860-3
Leuplinforection side effect was reported by a Consumer or non-health professional from JAPAN on June 04, 2008. Male patient, 64 years of age, weighting 133.8 lb, was diagnosed with prostate cancer stage iv, benign prostatic hyperplasia and was treated with Leuplinforection. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, prostate cancer . Leuplinforection dosage: unknown. During the same period patient was treated with BICALUTAMIDE, FOSFESTROL TETRA, ESTRAMUSTINE PHOSPHATE, HARNAL D, DEXAMETHASONE. Patient died on 03/01/2007.